XML 21 R10.htm IDEA: XBRL DOCUMENT v3.22.1
Note 4 - Cash, Cash Equivalents and Marketable Securities
3 Months Ended
Mar. 31, 2022
Notes to Financial Statements  
Cash, Cash Equivalents, and Marketable Securities [Text Block]
4.Cash, cash equivalents and marketable securities

 

The following is a summary of the Company's cash and cash equivalents as of the date indicated:

 
  

March 31, 2022

  

December 31, 2021

 
         

Cash in banking institutions

 $1,326,178  $30,308,075 

Money market funds

  5,046,607   7,005,483 

Commercial paper

  3,499,545    

Total

 $9,872,330  $37,313,558 

 

The following is a summary of the Company's marketable securities as of March 31, 2022:

 

  

Amortized cost

  

Unrealized gains

  

Unrealized losses

  

Fair Value

 
                 

Commercial paper

 $19,716,092  $  $(39,939) $19,676,153 

U.S. treasury bonds

  3,013,869      (9,719)  3,004,150 

Total

 $22,729,961  $  $(49,658) $22,680,303 

 

The Company did not have marketable securities as of December 31, 2021. The Company's marketable securities generally have contractual maturity dates between 3 and 12 months. Most of the Company’s marketable securities are in an unrealized loss position at March 31, 2022. Unrealized losses on marketable securities as of March 31, 2022 were not significant and were primarily due to changes in interest rates, and not due to increased credit risks associated with specific securities. Accordingly, no other-than-temporary impairment was recorded for the three months ended March 31, 2022 and there were no realized gains or losses recorded during the three months ended March 31, 2022.